The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of steroid-sparing agents (SSAs) for immune-related adverse events (irAEs) in patients (pts) discussed at a multidisciplinary immune-related adverse event (irAE) tumor board.
 
Kyle VanDommelen
No Relationships to Disclose
 
Lesil Brihn
No Relationships to Disclose
 
Cassandra Calabrese
Consulting or Advisory Role - AstraZeneca; Lilly
Speakers' Bureau - AstraZeneca; Sanofi
 
Keren Zhou
Consulting or Advisory Role - Atheneum
Speakers' Bureau - Xeris Pharmaceuticals
Research Funding - NS100; Siemens
 
Michael Smith MD
No Relationships to Disclose
 
Mamoun Abdoh
Other Relationship - UpToDate
 
Amy Kunchok
Consulting or Advisory Role - Alexion Pharmaceuticals
 
Jessica Philpott
Consulting or Advisory Role - Janssen
Speakers' Bureau - Abbvie
 
Shilpa Junna
No Relationships to Disclose
 
Gowri Kabbur
No Relationships to Disclose
 
Itunu Owoyemi
No Relationships to Disclose
 
Thach-Giao Truong
Consulting or Advisory Role - Iovance Biotherapeutics; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Castle Biosciences (Inst); Erasca, Inc (Inst); IDEAYA Biosciences (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis; Perspective Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; Genzyme; Gilead Sciences; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Tyra Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Pfizer
 
Halle Moore
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
 
Nathan Pennell
Consulting or Advisory Role - Anheart Therapeutics; bristol-myers sqibb; ConcertAI; Daiichi Sankyo; Genentech; Iovance Biotherapeutics; Janssen Oncology; Lilly; ResistanceBio; Takeda; Vial
Research Funding - Advenchen Laboratories (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); InhibRx (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Navire (Inst); Puma Biotechnology (Inst); Seattle Genetics/Astellas (Inst); Summit pharmaceuticals (Inst)
 
Wen Wee Ma
Honoraria - Ipsen; Taiho Oncology
Consulting or Advisory Role - Kodikaz Therapeutic Solutions
Research Funding - 1ST Biotherapeutics (Inst); Actuate Therapeutics (Inst); Athenex (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); CUE Biopharma (Inst); Elucida Oncology (Inst); Genentech (Inst); GI Innovation (Inst); Ipsen (Inst); Jacobio (Inst); Krystal Biotech (Inst); Lilly (Inst); Merus (Inst); Repare Therapeutics (Inst); Sun Pharma (Inst); Takeda (Inst)
 
Pauline Funchain
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Eisai; Immunocore; Merck; Replimune; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb (Inst); IDEAYA Biosciences (Inst); Pfizer (Inst); Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Merck
(OPTIONAL) Uncompensated Relationships - Nirvana Healthcare Ventures
 
Lucy Kennedy
Research Funding - EpicentRx; IDEAYA Biosciences; Regeneron